Oppenheimer reiterates AEHR target 120 and Outperform
The target change and reiteration set Oppenheimer’s updated valuation and rating stance for AEHR going into trading.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.